Rokitamycin

DB13409ExperimentalSmall molecule

Rokitamycin: Overview.

Chemical structure of Rokitamycin
Formula / weight
C42H69NO15 · 828.006 g/mol (avg)
Code names
TMS-19Q

Resolves to

Compound
UNIIZPT03UEM0ECAS74014-51-0ChEMBLCHEMBL1908350ChEBI32103
Clinical / RWD
ATCJ01FA12
Structure
InChIKeyVYWWNRMSAPEJLS-MDWYKHENSA-NSMILESCCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]2OC)[C@H](O)[C@H]1N(C)C

What you can answer from here — as of July 07, 2026

317Drug interactionsStructured to mechanism, not free text
Sign in
7Marketed productsAcross 2 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Rokitamycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In